The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The synergistic relationship between psychiatric medications and psychotherapy is often overlooked. By managing discreet ...

Esketamine (Spravato; Johnson & Johnson) is now the first and only monotherapy for adults with major depressive disorder (MDD ...

Europeans have a number of psychotropic compounds available ... studies in the literature that show its efficacy for the treatment of depression, and some data that show that it may be ...

Celebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...

The US Food and Drug Administration (FDA) has expanded the approval for Johnson & Johnson’s nasal spray Spravato to allow its standalone use in patients with depression, the company said on Jan 21.

The dilemma of prescribing psychiatric medications for a woman who has ... The number of women who present with postpartum depression has increased. The impact of social stresses may have ...

Tragically, since psychiatric medications were introduced in the ... Many of us are suffering from depression, anxiety, PTSD, psychosis as a result of organic and environmental factors.

Intra-Cellular has had success selling Caplyta, a brain-rebalancing drug that's approved to treat schizophrenia and bipolar ...